These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Changes in serum levels of receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, IL-6 and TNF-alpha in patients with a concomitant head injury and fracture. Lee JS, Ryu CH, Moon NH, Kim SJ, Park SY, Suh KT. Arch Orthop Trauma Surg; 2009 May; 129(5):711-8. PubMed ID: 18427820 [Abstract] [Full Text] [Related]
28. Tumour necrosis factor-related apoptosis-inducing ligand and osteoprotegerin serum levels in psoriatic arthritis. Hofbauer LC, Schoppet M, Christ M, Teichmann J, Lange U. Rheumatology (Oxford); 2006 Oct 15; 45(10):1218-22. PubMed ID: 16574701 [Abstract] [Full Text] [Related]
29. Receptor activator of NF(Kappa)B ligand/osteoprotegerin (RANKL/OPG) system and osteopontin (OPN) serum levels in a population of apulian postmenopausal women. D'Amore M, Fanelli M, D'Amore S, Fontana A, Minenna G. Panminerva Med; 2006 Dec 15; 48(4):215-21. PubMed ID: 17215793 [Abstract] [Full Text] [Related]
30. Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio. Seriwatanachai D, Thongchote K, Charoenphandhu N, Pandaranandaka J, Tudpor K, Teerapornpuntakit J, Suthiphongchai T, Krishnamra N. Bone; 2008 Mar 15; 42(3):535-46. PubMed ID: 18166509 [Abstract] [Full Text] [Related]
34. Bone mineral density, bone remodeling and osteoprotegerin in patients with acute coronary syndrome. Pérez-Castrillon JL, Abad L, Vega G, Sanz-Cantalapiedra A, San Miguel A, Mazón A, De Luis D, Dueñas-Laita A. Int J Cardiol; 2008 Sep 16; 129(1):144-5. PubMed ID: 17689752 [Abstract] [Full Text] [Related]
37. The ratio of messenger RNA levels of receptor activator of nuclear factor kappaB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis. Fazzalari NL, Kuliwaba JS, Atkins GJ, Forwood MR, Findlay DM. J Bone Miner Res; 2001 Jun 16; 16(6):1015-27. PubMed ID: 11393778 [Abstract] [Full Text] [Related]
39. Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease. García-Valdecasas-Campelo E, González-Reimers E, Santolaria-Fernández F, De la Vega-Prieto MJ, Milena-Abril A, Sánchez-Pérez MJ, Martínez-Riera A, Gómez-Rodríguez Mde L. Alcohol Alcohol; 2006 Jun 16; 41(3):261-6. PubMed ID: 16476762 [Abstract] [Full Text] [Related]
40. The "lively" cytokines network in beta-Thalassemia Major-related osteoporosis. Morabito N, Russo GT, Gaudio A, Lasco A, Catalano A, Morini E, Franchina F, Maisano D, La Rosa M, Plota M, Crifò A, Meo A, Frisina N. Bone; 2007 Jun 16; 40(6):1588-94. PubMed ID: 17412659 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]